GB2210265A - Dentifrice compositions - Google Patents

Dentifrice compositions Download PDF

Info

Publication number
GB2210265A
GB2210265A GB8723117A GB8723117A GB2210265A GB 2210265 A GB2210265 A GB 2210265A GB 8723117 A GB8723117 A GB 8723117A GB 8723117 A GB8723117 A GB 8723117A GB 2210265 A GB2210265 A GB 2210265A
Authority
GB
United Kingdom
Prior art keywords
composition according
dentifrice
cationic
sodium
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8723117A
Other versions
GB8723117D0 (en
Inventor
Martin Greensmith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Health and Beauty Care Ltd
Original Assignee
Richardson Vicks Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Ltd Great Britain filed Critical Richardson Vicks Ltd Great Britain
Priority to GB8723117A priority Critical patent/GB2210265A/en
Publication of GB8723117D0 publication Critical patent/GB8723117D0/en
Publication of GB2210265A publication Critical patent/GB2210265A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24Phosphorous; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

Dentifrice compositions comprise a pharmaceutically-acceptable carrier incorporating (a) from about 0.001% to about 20% by weight of a cationic antimicrobial agent; (b) from about 1% to about 20% of sodium or potassium chloride; and (c) from about 6% to about 90% of a calcium pyrophosphate dentifrice abrasive. The compositions display enhanced antiplaque and antigingivitis activity.

Description

ORAL COMPOSITIONS Technical Field The present invention relates to oral compositions.
In particular, the invention relates to dentifrice compositions having improved antigingival/antiplaque activity.
Backaround In normal healthy subjects, the oral gingivae are pink and firmly attached to the underlying alveolar bone.
Gingivitis, which is a condition in which the gingivae become inflamed, swell, and extrude fluid in the crevicular area between the enamel and the teeth, is believed to be related to accumulation of plaque at the enamel/gingival junction as a result of interaction between bacteria in the mouth with nutriants in saliva. It has been suggested that if the accumulation of plaque at the enamel/gingival junction can be prevented or retarded, the severity of gingivitis and periodontitis can be reduced.
The use of antimicrobial agents to reduce plaque has been recognised for many years. It has also been recognised that such agents can promote teeth staining problems, probably by inducing mineralization of plaque. Included among references disclosing oral compositions containing antimicrobials are; US Pat. No 3,937,805, Feb 10, 1976 to Harrison; US Pat. No.
3,937,807, Feb 10, 1976 to Haefele; US Pat. No.
4,080,441, Mar 21, 1978 to Gaffar et al; US Pat. No.
4,118,474, Oct 3, 1978 to Gaffar et al; US Pat. No.
4,370,314, Jan 25, 1983 to Gaffar; US Pat. No.
4,241,049, Dec 23, 1980 to Colodney et al; US Pat. No.
3,925,543, Dec 9, 1975 to Donohue; and US. Pat. No.
4,256,731, Mar 17, 1981 to Curtis et al.
The use of salt in dentifrices for oral hygiene purposes is also generally known in the art and dentifrice formulations containing salt have been marketed in Europe for a number of years. Salt, in higher concentrations, is believed to have a stimulating effect on the gum tissues, allegedly in its ability to draw body fluids out of the gums by osmotic pressure.
It now has been found that oral compositions combining certain cationic antimicrobial agents, salt and certain dentifrice abrasive materials are especially valuable from the viewpoint of providing enhanced antiplaque and antigingivitis activity and are also effective in controlling stain. While the antimicrobial compounds, abrasives, and salt are individually known for use in dentifrice compositions it would appear that the value of the combined system for improving antiplaque and antigingivitis efficacy has not been previously disclosed or appreciated in the art.
Summary of Invention Accordingly, the present invention provides a dentifrice composition comprising a pharmaceutically acceptable carrier incorporating: (a) from about 0.001% to about 20% by weight of a cationic antimicrobial agent; (b) from about 1% to about 20% of sodium or potassium chloride; and (c) from about 6% to about 90% of a calcium pyrophosphate dentifrice abrasive.
All percentages and ratios herein are by weight unless otherwise specified.
The antimicrobials used in the compositions of the present invention can be any of a wide variety of cationic antimicrobial agents such as quaternary ammonium compounds and substituted guanidines such as chlorhexidine and the corresponding compound alexidine. Mixtures of cationic antimicrobials may also be used in the present invention.
Antimicrobial quaternary ammonium compounds include those in which one or two of the substituents on the quaternary nitrogen has a carbon chain length (typically alkyl group) of some 8 to 20, typically 10 to 18 carbon atoms while the remaining substituents (typically alkyl or benzyl group) have a lower number of carbon atoms, such as 1 to 7 carbon atoms, typically methyl or ethyl groups. Dodecyl trimethyl ammonium bromide, tetradecyl pyridinium chloride, tetradecyl ethyl pyridinium chloride, dodecyl dimethyl (2-phenoxyethyl)ammonium bromide, benzyl dimethylstearyl ammonium chloride, cetyl pyridinium chloride, quaternized 5-amino-l,3-bis(2-ethyl-hexyl) -5-methyl hexahydropyrimidine and benzethonium chloride are exemplary of typical quaternary ammonium antibacterial agents.Other compounds are the bist4-(R-amino)-l-pyridinium] alkanes as disclosed in US Pat. No. 4,206,215, June 3, 1980 to Bailey. The pyridinium compounds are the preferred quaternary ammonium compounds.
The substituted guanidines of this invention include bisbiguanide compounds having generic formula.
wherein A and A' each represent either (1) a phenyl radical which optionally is substituted by an alkyl or alkoxy group containing from 1 to about 4 carbon atoms, a nitro group, or a halogen atom; (2) an alkyl group containing from about 1 to about 12 carbon atoms; or (3) alicyclic groups containing from 4 to about 12 carbon atoms; wherein X and X' each represent an alkylene radical containing from 1 to 3 carbon atoms; wherein Z and Z' each can either by 0 or 1; wherein R and R' each represent either hydrogen, an alkyl radical containing from 1 to about 12 carbon atoms, or an aralkyl radical containing from 7 to about 12 carbon atoms; wherein n is an integer from 2 to 12 inclusive; wherein the polymethylene chain (CH2)n may optionally be interupted by oxygen or sulfur atoms, aromatic nuclei, etc.The water soluble salts of the above compounds are preferred for use herein. Suitable water soluble salts include the chloride, the fluoride, and especially the acetate salt. The preferred substituted guanidine is chlorhexidine -(1, 6-di(-N5-pchlorophenyl -N-diguanido)hexane).
Of all the above, the preferred antimicrobial component of the oral compositions herein is an optionally substituted N-tetradecyl pyridinium compound and is preferably selected from the N-tetradecylpyridinium salts, N-tetradecyl4-ethylpyridinium salts and mixtures thereof.
The N-tetradecylpyridinium salt can be represented as follows:
wherein X- is an acid ion constituent such as fluoride chloride, bromide, iodide, nitrate, acetate, phenylsulfonate among many others. The preferred ions are the fluoride, chloride, bromide and iodide with chloride being the most preferred.
The tetradecylethylpyridinium salt has the ethyl group at the "4" position on the ring and can be represented similarly.
wherein X is as defined above.
The amount of antimicrobial agent used in the present compositions can be any amount that is safe to use in the mouth and capable of providing reduced plaque/gingivitis and breath odor. This amount will vary depending on the pharmaceutically acceptable carrier selected but generally is in the range of from 0.001% to about 20%, preferably from about 0.01% to about 7% more preferably from about 0.05% to about 1% by weight.
Another critical component of the invention is sodium or potassium chloride which is incorporated at a level of from about 1% to about 20%, preferably from about 4% to about 12% by weight of the composition.
The abrasive polishing component of the dentifrice compositions of the present invention is calcium pyrophosphate. In particular, it is a feature of the invention that the customary abrasives such as the silica dental abrasives are apparently unsuitable for compatability reasons in salt/cationic antimicrobial systems as defined.
The abrasive polishing materials useful herein generally have an average particle size ranging from about 0.1 to about 30 microns, preferably from about 5 to about 15 microns. The abrasive is generally present at a level of from about 6% to about 70%, preferably from about 15% to about 25% when the dentifrice is a toothpaste. Higher levels, as high as 90%, may be used if the composition is a toothpowder.
Flavoring agents can also be added to dentifrice compositions. Suitable flavoring agents include essential oils such as oil of wintergreen, oil of peppermint, oil of spearmint, oil of sassafras, and oil of clove. Sweetening agents which can be used include aspartame, acesulfame, saccharin, dextrose, levulose and sodium cyclamate. Flavoring and sweetening agents are generally used in dentifrices at levels of from about 0.005% to about 2% by weight.
Dentifrice compositions can also contain emulsifying agents. Suitable emulsifying agents are those which are reasonably stable and foam throughout a wide pH range, including non-soap anionic, nonionic, cat ionic, zwitterionic and amphoteric organic synthetic detergents. Many of these suitable surfactants are disclosed by Gieske et al., US Pat. No. 4,051,234, September 27, 1977.
It is common to have a water-soluble fluoride compound present in dentifrices in an amount sufficient to give a fluoride concentration of from about 0.0025% to about 5.0% by weight, preferably from about 0.005% to about 2.0% by weight, to provide additional anticaries effectiveness. Preferred fluorides are sodium fluoride, stannous fluoride, indium fluoride, and sodium monofluorophosphate. Norris et al., US Pat.
No. 2,946,735, issued July 26, 1960 and Widder et al., US Pat. No. 3,678,154, issued July 18, 1972 disclose such salts as well as others.
Another material useful in the present toothpastes is an anionic anticalculus agent. The anionic calculus inhibitors useful in the compositions of the present invention can be any of the agents which are known to provide calculus reduction. Many of such agents are disclosed in the references listed in the background section. Preferred agents include soluble pyrophosphate salts, soluble polycarboxylic salts (e.g., polyacrylic acid), and polyphosphates among many others. The anionic agent can be present at a level of from about 0.01% to about 10%, preferably from about 1% to about 5%.
Water is also present in the toothpastes of this invention. Water employed in the preparation of commercially suitable toothpastes should preferably be deionized and free of organic impurities. Water generally comprises from about 10% to 50, preferably from about 20% to 40%, by weight of the toothpaste composition herein. These amounts of water include free water which is added plus that which is introduced with other materials such as with sorbitol.
In preparing toothpastes, it is necessary to add some thickening material to provide a desirable consistency. Suitable thickening agents include carboxyvinyl polymers such as the Carbopols (RTM), carrageenan (lambda, kappa and iota forms and mixtures thereof), hydroxyethyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, starch, starch glycolate, polyvinyl alcohol, sodium alginate and water soluble salts of cellulose ethers such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxyethyl cellulose. Natural gums such as gum karaya, xanthan gum, gum arabic, and gum tragacanth can also be used.
Thickening agents in an amount from 0.2% to 5.0% preferably from about 0.5% to about 2.0% by weight of the total composition can be used. Colloidal magnesium aluminum silicate or finely divided silica such as Silodent 15, Cab-O-Sil M-5, Syloid 244, Syloid 266 and Aerosil D200 can also be added in amounts of from about 0.5% to about 20% to further improve texture.
It is also desirable to include some humectant material in a toothpaste to keep it from hardening.
Suitable humectants include glycerin, sorbitol, and other edible polyhydric alcohols such as polyethylene glycols, mannitols, sugar alcohols and polyoxyethylene alcohols. The humectant is normally present at a level of from about 15% to about 70%, preferably from about 20% to about 50% by weight of composition.
The pH of the present composition and/or its pH in the mouth can be any pH which is safe for the mouth's hard and soft tissues. Such pH's are generally from about 3 to about 10, preferably from about 4 to about 8.
EXAMPLES I - IV The following are representative compositions of the present invention. The compositions are prepared by mixing the sorbitol, glycerine, fluoride, sweetener and water in a mix tank at a temperature of from about 60"C. to about 80"C., adding the remaining components with the antimicrobial last, mixing under vacuum for about 30 minutes and packing.
Components Weight % I II III IV Sodium fluoride 0.3 - 0.3 0.3 Sodium chloride 7.5 5 9 10 Natrosol 250M1 1 1.5 1 1.5 Glycerine 7 6 8 5 Sorbitol (70%) solution 14 15 13 16 Calcium pyrophosphate 40 40 40 40 Titanium dioxide 0.4 0.4 0.4 0.4 PEG40-SD1S2 0.6 0.6 0.6 0.6 Acesulfam - K3 0.4 0.4 0.4 0.4 Flavour 2 2 2 2 Colour 0.05 0.05 0.05 0.05 HC1 (1M) 0.5 0.5 0.5 0.5 TDEPC4 0.7 1.1 - 0.9 Chlorhexidine - - 0.8 Azulene 0.05 - - 0.05 Double reverse osmosis water ~~~~~~~~~~~to to 100 100 1. Natrosol 250M Hydroxyethylcellulose supplied by Hercules Inc.
2. PEG40-SD1S PEG40-sorbitan diisostearate 3. Acesulfam-K Potassium salt of 3,4-dihydro-6-methyl-1,2,3, -oxathiazin-4-on-2,2-dioxide 4. TDEPC Tetradecylethylpyridinium chloride.
The compositions display excellent antiplaque and antigingivitis efficacy and improved stain control.

Claims (7)

1. A dentifrice composition comprising a pharmaceutically-acceptable carrier incorporating (a) from about 0.001% to about 20% by weight of a cationic antimicrobial agent; (b) from about 1% to about 20% of sodium or potassium chloride; and (c) from about 6% to about 90% of a calcium pyrophosphate dentifrice abrasive.
2. A composition according to Claim 1 wherein the cationic antimicrobial agent is selected from quaternary ammonium and substituted guanidine compounds and mixtures thereof.
3. A composition according to Claim 2, wherein the cationic antimicrobial agent is an optionally substituted C10-C18 alkyl pyridinium compound.
4. A composition according to Claim 3 wherein the cationic anti-microbial agent is an optionally substituted N-tetradecyl pyridinium compound.
5. A composition according to Claim 4 wherein the cationic microbial agent is selected from N-tetradecyl pyridinium salts and N-tetradecyl-4-ethyl-pyridinium salts and mixtures thereof.
6. A composition according to any of Claims 1 to 5 comprising from about 0.01% to about 7%, preferably from about 0.05% to about 1% of the antimicrobial.
7. A composition according to any of Claims 1 to 6 comprising from about 4% to about 12% of sodium chloride or potassium chloride.
GB8723117A 1987-10-02 1987-10-02 Dentifrice compositions Withdrawn GB2210265A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8723117A GB2210265A (en) 1987-10-02 1987-10-02 Dentifrice compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8723117A GB2210265A (en) 1987-10-02 1987-10-02 Dentifrice compositions

Publications (2)

Publication Number Publication Date
GB8723117D0 GB8723117D0 (en) 1987-11-04
GB2210265A true GB2210265A (en) 1989-06-07

Family

ID=10624680

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8723117A Withdrawn GB2210265A (en) 1987-10-02 1987-10-02 Dentifrice compositions

Country Status (1)

Country Link
GB (1) GB2210265A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0568160A2 (en) * 1988-10-13 1993-11-03 Beecham Group Plc Toothpaste
US5318772A (en) * 1991-12-10 1994-06-07 The Dow Chemical Company Oral compositions for inhibiting calculus formation
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
WO2023049356A1 (en) * 2021-09-23 2023-03-30 Colgate-Palmolive Company Oral care compositions and methods of use

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4021386A1 (en) * 2020-03-27 2022-07-06 Colgate-Palmolive Company Oral care compositions and methods of use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887712A (en) * 1973-06-15 1975-06-03 Merck & Co Inc Oral hygiene products
US3989814A (en) * 1975-01-28 1976-11-02 Colgate-Palmolive Company Calcium pyrophosphate abrasive system for dentifrice
US4157387A (en) * 1974-05-21 1979-06-05 The Procter & Gamble Company Dentifrice composition containing an abrasive coated with a cationic water soluble polymer
US4327079A (en) * 1979-11-15 1982-04-27 Dental Chemical Co., Ltd. Dentifrice compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887712A (en) * 1973-06-15 1975-06-03 Merck & Co Inc Oral hygiene products
US4157387A (en) * 1974-05-21 1979-06-05 The Procter & Gamble Company Dentifrice composition containing an abrasive coated with a cationic water soluble polymer
US3989814A (en) * 1975-01-28 1976-11-02 Colgate-Palmolive Company Calcium pyrophosphate abrasive system for dentifrice
US4327079A (en) * 1979-11-15 1982-04-27 Dental Chemical Co., Ltd. Dentifrice compositions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0568160A2 (en) * 1988-10-13 1993-11-03 Beecham Group Plc Toothpaste
EP0568160A3 (en) * 1988-10-13 1994-01-12 Beecham Group Plc
US5318772A (en) * 1991-12-10 1994-06-07 The Dow Chemical Company Oral compositions for inhibiting calculus formation
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
WO2023049356A1 (en) * 2021-09-23 2023-03-30 Colgate-Palmolive Company Oral care compositions and methods of use

Also Published As

Publication number Publication date
GB8723117D0 (en) 1987-11-04

Similar Documents

Publication Publication Date Title
US4994262A (en) Oral compositions
US4980153A (en) Antiplaque oral hygiene composition
EP0577306B1 (en) Oral hygiene composition
US5833958A (en) Dentifrice compositions
US5389360A (en) Oral compositions
US10576033B2 (en) Dentifrice comprising zinc-amino acid complex
AU4775493A (en) Oral compositions
JPS6332763B2 (en)
JPH10505831A (en) Oral composition
GB2210264A (en) Antigingival/antiplaque compositions
US20040258631A1 (en) Oral care compositions exhibiting antiplaque and breath freshening properties
GB2210265A (en) Dentifrice compositions
US6440395B1 (en) Antiplaque mouth rinse
US5496539A (en) Oral compositions
JP3241922B2 (en) Oral composition
EP0510151A1 (en) Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and anti-microbial agent.
JPH09143042A (en) Composition for oral cavity
US4279889A (en) Periodontal dental composition
GB2133689A (en) Plaque-inhibiting oral compositions containing carboxylic acids
EP1041959A1 (en) Compositions for inhibiting gingivitis
WO1992013514A1 (en) Oral compositions containing bromochlorophene and zinc ions
JPH0419205B2 (en)
JPH07258052A (en) Composition for oral cavity
GB2048668A (en) Periodontal preparations containing folic acid

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)